Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

The technology behind the weekly pill is as much mechanical as it is pharmaceutical. Encased in a standard-size capsule is a ...

The capsule expands into a six-armed star shape that remains in the stomach and releases drugs for up to a week The device maintained a steady flow of schizophrenia medication and kept symptoms stable ...

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common side effect of antipsychotic drugs.

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...

Psychedelic drugs, such as lysergic acid diethylamide (LSD), can increase neuronal growth, which can have therapeutic effects for conditions such as schizophrenia. However, such drugs can induce ...

Whether the drug outperforms existing drugs or makes a significant dent in schizophrenia’s negative and cognitive symptoms, often the most disabling ones for people with this illness, is also ...

Supplements that may improve symptoms of schizophrenia and its treatment include omega-3 fatty acids, B vitamins, vitamin E, zinc, magnesium, and N-acetylcysteine.

Whether the drug outperforms existing drugs or makes a significant dent in schizophrenia’s negative and cognitive symptoms, often the most disabling ones for people with this illness, is also ...

About 3.7 million, or 1.8%, of adults in the U.S. have a lifetime history of schizophrenia, according to research published in 2023. The estimate was two to three times higher than previous estimates.